Promising results after CAR T-cell therapy for leukemia and lymphoma

by

Swedish cancer patients treated with CAR T-cell therapy show better survival rates and fewer side effects than seen in previous studies. This is shown in a new compilation of Swedish treatment results conducted by researchers in the SWECARNET network.

Leave A Comment

Your email address will not be published. Required fields are marked *